Life Extending Drugs: A Canary in the Coal Mine for UK Healthcare Reforms The recent decision to make Enhertu available to patients with incurable breast cancer on the NHS marks a significant development in the UK's healthcare landscape.
This breakthrough raises questions about the state of Britain's healthcare system and its ability to adapt to emerging medical technologies.
Enhertu has a relatively long history, having been available on the NHS in Scotland since 2023 and in other European countries for even longer.